- জেনেরিক নাম
- Glimepiride
- শক্তি
- 2 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Supreme Pharmaceuticals Ltd.
৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Limerid হলো Glimepiride-এর একটি ব্র্যান্ড, শক্তি ২ mg, ট্যাবলেট আকারে। এই ব্র্যান্ডের প্রস্তুতকারক Supreme Pharmaceuticals Ltd। Limerid-এর সাথে Glimepiride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Limerid-এর প্রতি ইউনিটের দাম ৫ টাকা। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Glimepiride-এর ৪১টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৫টি। সবচেয়ে কম দাম Mepid 1 mg Tablet-এর, প্রতি ইউনিট ৳ ২.৫১।
Limerid 2 mg tablet is a medicine made by Supreme Pharmaceuticals Ltd. It is used as an adjunct to diet and exercise to lower blood glucose in patients with non-insulin dependent (Type II) diabetes mellitus whose hyperglycaemia cannot be controlled by diet and exercise alone. It may also be used with metformin when diet, exercise, and either Glimepiride or metformin alone do not provide adequate glycaemic control. The dose and duration are set by the doctor based on regular blood sugar checks.
It may also be prescribed alongside metformin when diet, exercise and either medicine alone do not give adequate control. Only a doctor can decide whether it suits a particular patient. It may also be used together with metformin when diet, exercise, and Glimepiride or metformin alone do not result in adequate glycaemic control. Your doctor will decide if it is suitable for you.
Swallow the tablet with water. Limerid is taken by mouth. Do not stop taking Limerid without talking to your doctor first. Do not change the dose yourself or stop the medicine without speaking to your doctor.
Your doctor can tell you how to recognise and manage low blood sugar. If you experience symptoms of low blood sugar, take carbohydrates such as glucose or sugar immediately and contact your doctor. Low blood sugar can be quickly treated by taking glucose or sugar, but always follow your doctor's advice. Tell your doctor if any side effect bothers you or does not go away.
The risk of hypoglycaemia may be higher in the first weeks of treatment, so careful monitoring is needed. If you are planning a pregnancy, tell your doctor before you start. It is also not for people with severe liver or kidney problems or on dialysis.
It may also be prescribed alongside metformin when diet, exercise and either medicine alone do not give adequate control. Only a doctor can decide whether it suits a particular patient.
Swallow the tablet with water. Limerid is taken by mouth.
Your doctor can tell you how to recognise and manage low blood sugar. If you experience symptoms of low blood sugar, take carbohydrates such as glucose or sugar immediately and contact your doctor.
The listed price is ৳ ৫.০০.
৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is indicated in following conditions-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Keep away from light and out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।